Predictive Value of PD-L1 Expression and dMMR/pMMR Status for Immune Checkpoint Inhibitor Combined with Chemotherapy in Advanced/Recurrent Endometrial Cancer: A Meta-Analysis
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Endometrial and Cervical Cancer Treatments
Breast Cancer Treatment Studies
Publication details
- Publication date
- 6 March 2026
- Language
- EN